- Home
- RPTX vs CCIF Comparison
RPTX vs CCIF Comparison
Compare RPTX & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPTX | CCIF |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.4M | 110.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPTX | CCIF |
|---|---|---|
| Price | $2.16 | $4.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 808.3K | 76.9K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 25.90% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,870,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $7.43 |
| 52 Week High | $2.30 | $10.16 |
Technical Indicators
Market Signals| Indicator | RPTX | CCIF |
|---|---|---|
| Relative Strength Index (RSI) | 57.28 | 38.18 |
| Support Level | $2.11 | $4.60 |
| Resistance Level | $2.27 | $4.94 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 41.18 | 28.77 |
Price Performance
Historical ComparisonAbout RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.